A detailed history of Spectrum Management Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Spectrum Management Group, LLC holds 560 shares of VRTX stock, worth $228,580. This represents 0.04% of its overall portfolio holdings.

Number of Shares
560
Holding current value
$228,580
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$273.83 - $305.53 $153,344 - $171,096
560 New
560 $162,000
Q4 2021

Feb 03, 2022

SELL
$177.01 - $223.45 $2,832 - $3,575
-16 Reduced 2.78%
560 $123,000
Q3 2021

Nov 03, 2021

BUY
$181.39 - $202.99 $2,902 - $3,247
16 Added 2.86%
576 $104,000
Q1 2020

May 08, 2020

BUY
$199.77 - $247.81 $111,871 - $138,773
560 New
560 $133,000
Q4 2019

Feb 04, 2020

SELL
$166.71 - $223.91 $93,357 - $125,389
-560 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$151.91 - $192.21 $85,069 - $107,637
560 New
560 $93,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Spectrum Management Group, LLC Portfolio

Follow Spectrum Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Management Group, LLC with notifications on news.